The Development of Anemia Is Associated to Poor Prognosis in NKF/KDOQI Stage 3 Chronic Kidney Disease

BMC Nephrology - United Kingdom
doi 10.1186/1471-2369-14-2
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Peripheral Arterial Disease Holding Central Stage in Chronic Kidney Disease (Kdoqi Stage 3-5): Prevalance and Related Risk Factors-Experience From Kashmir Valley Teritary Care Centre

SM Journal of Nephrology and Kidney Diseases
2017English

Subclinical Cardiopulmonary Dysfunction in Stage 3 Chronic Kidney Disease

Open Heart
Cardiovascular MedicineCardiology
2016English

The Compatibility of the Treatment of Chronic Kidney Disease and Diabetes to the KDOQI-2012 Update Guideline

Turkish Journal of Endocrinology and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Galectin-3 Is Associated With a Poor Prognosis in Primary Hepatocellular Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

High Neutrophil/Lymphocyte Ratio Is Associated With Poor Renal Outcomes in Japanese Patients With Chronic Kidney Disease

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2019English

Methylation of MGMT Is Associated With Poor Prognosis in Patients With Stage III Duodenal Adenocarcinoma

PLoS ONE
Multidisciplinary
2016English

Upregulation of E2F Transcription Factor 3 Is Associated With Poor Prognosis in Hepatocellular Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2014English

Chronic Kidney Disease Is Associated With Greater Bone Marrow Adiposity

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2018English

Correction: Phosphatase of Regenerating Liver-3 (PRL-3) Is Associated With Metastasis and Poor Prognosis in Gastric Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy